Across TCGA pan-cancer cohorts, MIR5691 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR5691 data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR5691 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR5691 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.
BRCA, UVM, and KICH are the cancer types where MIR5691 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.